Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e

Nuclear paraspeckle assembly transcript 1 (NEAT1), a long non-coding RNA, promotes oncogenesis in various tumors, including human gliomas. Herein, we studied the expression and function of NEAT1 in glioma stem cells (GSCs). Quantitative real-time PCR demonstrated that NEAT1 was upregulated in GSCs. NEAT1 knockdown inhibited GSC cell proliferation, migration and invasion and promoted GSC apoptosis. A potential binding region between NEAT1 and microRNA let-7e was confirmed by dual-luciferase assays. Upregulation of NEAT1 reduced the expression of let-7e, and there was reciprocal repression between NEAT1 and let-7e in an Argonaute 2-dependent manner. Let-7e expression was lower expression in glioblastoma tissues and GSCs than in normal brain tissues and cells. Restoration of let-7e suppressed tumor function by inhibiting proliferation, migration and invasion while promoting apoptosis in GSCs. NEAT1 knockdown and let-7e overexpression both reduced NRAS protein expression. NRAS was identified as a direct target of let-7e and promoted oncogenesis in GSCs. As NEAT1 promoted oncogenesis by downregulating let-7e expression, both of these genes could be considered for application in glioma therapy.

[1]  John N. Hutchinson,et al.  A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains , 2007, BMC Genomics.

[2]  F. Slack,et al.  The let-7 family of microRNAs. , 2008, Trends in cell biology.

[3]  John N. Hutchinson,et al.  An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. , 2009, Molecular cell.

[4]  S. Paternot,et al.  Combined inhibition of MEK and mammalian target of rapamycin abolishes phosphorylation of cyclin-dependent kinase 4 in glioblastoma cell lines and prevents their proliferation. , 2009, Cancer research.

[5]  Y. Kim,et al.  Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma , 2010, BMC Cancer.

[6]  Patrick Mayeux,et al.  Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia , 2010, Haematologica.

[7]  B. Györffy,et al.  Biomarkers downstream of RAS: a search for robust transcriptional targets. , 2010, Current cancer drug targets.

[8]  Jiayi Wang,et al.  CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer , 2010, Nucleic acids research.

[9]  Sun-Mi Park,et al.  The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.

[10]  Xiao-guang Liu,et al.  miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes , 2012, Journal of Cancer Research and Clinical Oncology.

[11]  A. González-Angulo,et al.  Targeting the PI3K signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.

[12]  J. Visvader,et al.  Cancer stem cells: current status and evolving complexities. , 2012, Cell stem cell.

[13]  Joel Greshock,et al.  Genomic DNA Copy-Number Alterations of the let-7 Family in Human Cancers , 2012, PloS one.

[14]  C Yang,et al.  Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin , 2013, Oncogenesis.

[15]  W. Sellers,et al.  Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer , 2013, Nature Medicine.

[16]  L. Ricci-Vitiani,et al.  Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas , 2012, Cell Death and Differentiation.

[17]  Shan-shan Liu,et al.  Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma , 2014, Biomedical reports.

[18]  miRNA let-7e targeting MMP9 is involved in adipose-derived stem cell differentiation toward epithelia , 2014, Cell Death and Disease.

[19]  Xiao-guang Liu,et al.  Differential Expression of miR-125a-5p and let-7e Predicts the Progression and Prognosis of Non-Small Cell Lung Cancer , 2014, Cancer investigation.

[20]  M. Caligiuri,et al.  Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  Eugenia G. Giannopoulou,et al.  The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.

[22]  Y Zhang,et al.  MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1. , 2014, Indian journal of cancer.

[23]  R. Dahiya,et al.  Long Non-coding RNA HOTAIR Is Targeted and Regulated by miR-141 in Human Cancer Cells* , 2014, The Journal of Biological Chemistry.

[24]  Gang Chen,et al.  Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. , 2015, International journal of clinical and experimental pathology.

[25]  Jian Zheng,et al.  CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186 , 2015, Oncotarget.

[26]  A. Iafrate,et al.  Impact of NRAS Mutations for Patients with Advanced Melanoma Treated with Immune Therapies , 2015, Cancer Immunology Research.

[27]  G. Blandino,et al.  Oncogenic MicroRNAs: Key Players in Malignant Transformation , 2015, Cancers.

[28]  D. Bates,et al.  LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma , 2015, Oncotarget.

[29]  Jing Liu,et al.  Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Jun Ma,et al.  Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. , 2015, Cellular signalling.

[31]  Jun Ma,et al.  MiR‐449a exerts tumor‐suppressive functions in human glioblastoma by targeting Myc‐associated zinc‐finger protein , 2015, Molecular oncology.

[32]  Jie Gao,et al.  Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases , 2015, Scientific Reports.

[33]  Jinyong Wang,et al.  Oncogenic NRAS hyper-activates multiple pathways in human cord blood stem/progenitor cells and promotes myelomonocytic proliferation in vivo. , 2015, American journal of translational research.

[34]  L. Zhen,et al.  Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis , 2015, Tumor Biology.

[35]  Zhuo Xi,et al.  Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. , 2015, Cancer letters.

[36]  Douglas B. Johnson,et al.  Treatment of NRAS-Mutant Melanoma , 2015, Current Treatment Options in Oncology.

[37]  M. Esteller,et al.  lncRNAs and microRNAs with a role in cancer development. , 2016, Biochimica et biophysica acta.

[38]  J. Utikal,et al.  MAP kinase pathway gene copy alterations in NRAS/BRAF wild‐type advanced melanoma , 2016, International journal of cancer.

[39]  Peng Wang,et al.  Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway , 2016, Journal of Experimental & Clinical Cancer Research.

[40]  Shu Yang,et al.  A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells. , 2016, The international journal of biochemistry & cell biology.

[41]  J. K. Cheong,et al.  The renewed battle against RAS-mutant cancers , 2016, Cellular and Molecular Life Sciences.

[42]  H. Zhuang,et al.  Downregulation of let-7e-5p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis via targeting FASLG. , 2016, Thrombosis research.

[43]  C. Yeh,et al.  Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients , 2016, Oncotarget.

[44]  G. Saldanha,et al.  MicroRNA-21 expression and its pathogenetic significance in cutaneous melanoma , 2016, Melanoma research.

[45]  O. Pardo,et al.  miR‐515‐5p controls cancer cell migration through MARK4 regulation , 2016, EMBO reports.

[46]  E. Bar,et al.  Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells , 2015, Oncotarget.

[47]  Jian Zheng,et al.  CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  Lei Yang,et al.  Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer , 2016, Oncotarget.